State of the art: systemic rosacea management.

J Dtsch Dermatol Ges

Department of Dermatology and UCD Charles Institute for Translational Dermatology,  University College Dublin, Dublin, Ireland.

Published: December 2016

Based on numerous trials, oral tetracyclines and most commonly their second-generation derivative doxycycline have become the main pillar in systemic rosacea treatment. However, the only preparation that has been approved so far in this setting is 40 mg doxycycline in an anti-inflammatory dosage and with a modified release formulation. With the introduction of this once-daily, non-antibiotic dosing of doxycycline, oral therapy is more commonly prescribed as first-line treatment in moderate to severe papulopustular rosacea. In addition, topical and oral strategies are often used in combination due to the more substantial improvements compared to monotherapy. Although several other non-approved oral agents like macrolides, isotretinoin, and carvedilol have been evaluated for systemic treatment and showed promising results, yet the experience with these drugs in rosacea is limited, and thus they should be reserved for special situations.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13141DOI Listing

Publication Analysis

Top Keywords

systemic rosacea
8
state art
4
art systemic
4
rosacea
4
rosacea management
4
management based
4
based numerous
4
numerous trials
4
oral
4
trials oral
4

Similar Publications

Macrophages in inflammatory skin diseases and skin tumors.

Front Immunol

December 2024

Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Article Synopsis
  • - Macrophages are key immune cells that play diverse roles in the body, especially in the skin, which is the largest immune organ and is crucial for studying various skin-related conditions.
  • - This review focuses on recent findings about macrophages in inflammatory skin diseases like atopic dermatitis and psoriasis, as well as skin tumors such as melanoma and cutaneous T-cell lymphoma.
  • - The goal is to enhance understanding of how macrophages contribute to these diseases and explore potential new treatments targeting them.
View Article and Find Full Text PDF

Impaired Angiogenesis and Th1/Th17 Polarization: A Possible Explanation for the Decreased Incidence of Rosacea in the Aged.

Immun Inflamm Dis

December 2024

Department of Dermatology, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changsha, China.

Background: Rosacea is a common inflammatory skin disorder characterized by frequent facial flushing, erythema, telangiectasia, and papules, with a higher incidence observed in individuals aged 30-50 years and a tendency to decrease in the elderly. This age-related decline in incidence drew our attention to further explore the relationship between rosacea pathogenesis and aging.

Methods: We analyzed the incidence of rosacea across 8340 individuals without systemic diseases.

View Article and Find Full Text PDF

Purpose: Observational studies have suggested a potential link between emotions and inflammatory dermatoses. However, research on the causal relationship between different types of emotions and inflammatory dermatoses is lacking. This study is aimed to investigate the causal relationship between negative emotions and inflammatory dermatoses through Mendelian randomization (MR) analysis.

View Article and Find Full Text PDF

Introduction: Rosacea is a chronic inflammatory disease presenting with facial flushing, non-transient erythema, papules/pustules, telangiectasia, and phymatous changes. Secondary manifestations, such as itching, burning, or stinging, are often observed in patients with rosacea. The pathogenesis of rosacea is not fully understood, but immune dysfunction, Demodex infection, neurovascular dysregulation, and exposure to ultraviolet radiation represent contributing factors.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic immune system abnormalities may play a role in rosacea development, with studies indicating a higher presence of abnormal bacteria and small intestinal bacterial overgrowth (SIBO) in affected individuals, though inconsistent testing has led to discrepancies in findings.* -
  • This study aimed to accurately assess the prevalence of abnormal bacteria and SIBO in individuals with rosacea while controlling for potential confounding factors, excluding those with gastrointestinal diseases or significant health issues.* -
  • Findings showed that 14.8% tested positive for abnormal bacteria and 33.3% for SIBO, with a notably higher SIBO rate in the rosacea cohort compared to the general population, suggesting a possible link between SIBO and ros
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!